76
|
Uhry Z, Belot A, Colonna M, Bossard N, Rogel A, Grosclaude P, Remontet L. Comparaison de trois méthodes d’estimation de l’incidence nationale pour 22 cancers en France. Rev Epidemiol Sante Publique 2012. [DOI: 10.1016/j.respe.2012.06.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
77
|
Leclère B, Molinié F, Daubisse-Marliac L, Grosclaude P, Trétarre B, Colonna M. Évolution de l’incidence des cancers du sein chez la femme jeune en Europe du sud de 1990 à 2008. Rev Epidemiol Sante Publique 2012. [DOI: 10.1016/j.respe.2012.06.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
78
|
Wang Y, Swiecki M, Cella M, Alber G, Schreiber R, Gilfillan S, Colonna M. O032 Timing and magnitude of Type I interferon responses by distinct viral sensors impact CD8 T cell exhaustion and chronic infection. Cytokine 2012. [DOI: 10.1016/j.cyto.2012.06.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
79
|
Kabtoul M, Bougault R, Colonna M, Galichet E. Chemistry of nuclear particle production in 32 A MeV136,124Xe+124,112Sn reactions and nuclear symmetry energy. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20123100010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
80
|
Napolitani P, Colonna M. Boltzmann-Langevin one-body dynamics for fermionic systems. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20123100027] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
81
|
Shao GY, Colonna M, Di Toro M, Liu B, Matera F. Influence of vector interactions on the hadron-quark/gluon phase transition. Int J Clin Exp Med 2012. [DOI: 10.1103/physrevd.85.114017] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
82
|
Politi G, Pirrone S, Commara ML, Wieleczko J, Ademard G, Filippo ED, Vigilante M, Amorini F, Auditore L, Beck C, Berceanu I, Bonnet E, Borderie B, Cardella G, Chbihi A, Colonna M, D'Onofrio A, Frankland J, Geraci E, Henry E, LaGuidara E, Lanzalone G, Lautesse P, Lebhertz D, LeNeindre N, Lombardo I, Loria D, Mazurek K, Pagano A, Papa M, Piasecki E, Porto F, Quinlann M, Rizzo F, Rosato E, Russotto P, Schroeder W, Spadaccini G, Trifirò A, Verde G. Study and comparison of the decay modes of the systems formed in the reactions78Kr+40Ca and86Kr+48Ca at10AMeV. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20122102003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
83
|
Russotto P, Acosta L, Adamczyk M, Al-Ajlan A, Al-Garawi M, Al-Homaidhi S, Amorini F, Auditore L, Aumann T, Ayyad Y, Baran V, Basrak Z, Benlliure J, Boiano C, Boisjoli C, Boretzky K, Brzychczyk J, Budzanowski A, Cardella G, Cammarata P, Cavallaro S, Chajecki Z, Chartier M, Chbihi A, Colonna M, Czech B, De Filippo E, Di Toro M, Famiano M, Le Fevre A, Gašsparić A, Geraci E, Grassi L, Greco V, Guazzoni C, Guazzoni P, Heil M, Heilborn L, Introzzi R, Isobe T, Kezzar K, Kiš M, Kupny S, Kurz N, La Guidara E, Lanzalone G, Lasko P, Leifels Y, Lemmon R, Li Q, Lombardo I, Loria D, Lukasik J, Lynch W, Marini P, Matthews Z, May L, Minniti T, Mostazo M, Pagano A, Papa M, Pawlowski P, Petrovici M, Pirrone S, Politi G, Porto F, Reifarth R, Reisdorf W, Riccio F, Rizzo F, Rosato E, Rossi D, Santoro S, Simon H, Skwirczynska I, Sosin Z, Trautmann W, Trifirò A, Trimarchi M, Tsang B, Veselsky M, Verde G, Vigilante M, Wieloch A, Wigg P, Wilczynski J, Wolter H, Wu P, Yennello S, Zambon P, Zetta L, Zoric M. ASY-EOS experiment at GSI. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20123100012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
84
|
La Commara M, Pirrone S, Politi G, Wieleczko J, Ademard G, De Filippo E, Vigilante M, Amorini F, Auditore L, Beck C, Berceanu I, Bonnet E, Borderie B, Cardella G, Chbihi A, Colonna M, D’Onofrio A, Frankland JD, Geraci E, Henry E, La Guidara E, Lanzalone G, Lautesse P, Lebhertz D, Le Neindre N, Lombardo I, Loria D, Mazurek K, Pagano A, Papa M, Piasecki E, Porto F, Quinlannl M, Rizzo F, Rosato E, Russotto P, Schroeder WU, Spadaccini G, Trifirò A, Tõke J, Trimarchi M, Verde G. Decay modes of the systems formed in the reactions 78Kr+ 40Ca and 86Kr+ 48Ca. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20123100022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
85
|
Galichet E, Rivet MF, Gagnon-Moisan F, Borderie B, Colonna M, Roy R. Isospin effects in central heavy-ion collisions at Fermi energy. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20123100017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
86
|
Colonna M. Isovector fluctuations and symmetry energy in fragmentation dynamics. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20123100013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
87
|
Fuchs A, Colonna M. Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity. Eur J Microbiol Immunol (Bp) 2011; 1:257-66. [PMID: 24516732 DOI: 10.1556/eujmi.1.2011.4.1] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2011] [Accepted: 10/11/2011] [Indexed: 12/30/2022] Open
Abstract
Natural killer (NK) cells are innate lymphocytes that play important roles in the defense against microbial pathogens through secretion of IFN-γ and recognition and lysis of virally or bacterially infected host cells. A recently identified population of NK-like cells that shares characteristics of both NK cells and lymphoid tissue inducer (LTi) cells promotes innate immune responses in epithelial tissue through the secretion of IL-22. In contrast to classical NK cells, NK-like cells are localized preferentially at mucosal sites, such as the intestinal mucosa. In this review, we consider the function of NK and NK-like cells in anti-microbial defense as well as the maintenance of tissue integrity in the mucosal epithelium of the intestine, lung, and female reproductive tract. Current experimental evidence supports an important protective role for IL-22-producing NK-like cells during intestinal infections, whereas classical NK cells are crucial in the early defense against many pathogens in the respiratory tract. NK cells isolated from the pregnant uterus differ significantly in phenotype and function from those at other tissue locations. Uterine NK cells clearly contribute to the tissue remodeling that takes place during placentation, but their role in anti-microbial defense remains largely undefined.
Collapse
|
88
|
Pirrone S, Politi G, La Commara M, Wieleczko J, Ademard G, De Filippo E, Vigilante M, Amorini F, Auditore L, Beck C, Berceanu I, Bonnet E, Borderie B, Cardella G, Chbihi A, Colonna M, D’Onofrio A, Frankland J, Geraci E, Henry E, La Guidara E, Lanzalone G, Lautesse P, Lebhertz D, Le Neindre N, Lombardo I, Loria D, Mazurek K, Pagano A, Papa M, Piasecki E, Porto F, Quinlann M, Rizzo F, Rosato E, Russotto P, Schroeder W, Spadaccini G, Trifirò A, Toke J, Trimarchi M, Verde G. ISODEC Experiment: study and comparison of the decay mode of78Kr+40Ca and86Kr+48Ca systems at 10 AMeV. EPJ WEB OF CONFERENCES 2011. [DOI: 10.1051/epjconf/20111716010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
89
|
Nagy-Mignotte H, Guillem P, Vesin A, Toffart AC, Colonna M, Bonneterre V, Brichon PY, Brambilla C, Brambilla E, Lantuejoul S, Timsit JF, Moro-Sibilot D. Primary lung adenocarcinoma: characteristics by smoking habit and sex. Eur Respir J 2011; 38:1412-9. [PMID: 21828037 DOI: 10.1183/09031936.00191710] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The incidence of adenocarcinoma is increasing, particularly among females. We sought to assess the role of tobacco consumption in clinical presentation according to sex. In this retrospective study, 848 patients diagnosed between 1997 and 2006 at Grenoble University Hospital (Grenoble, France) were stratified into four groups according to smoking habits. Differences between sexes and two contrasting female profiles emerged. Female current smokers were younger than female never-smokers (median 51 versus 69 yrs; p < 0.001), more often had surgery (62.7% versus 39%; p = 0.01) and had a median (95% CI) estimated survival of 26.2 (18.1-49.2) versus 15.1 (12.8-22.2) months (p = 0.002). Both groups had similar survival when taking treatment into account. Among males, smoking did not influence presentation. Male current smokers were older than female current smokers (median 59 yrs; p < 0.001) and fewer had surgery (48.8%; p = 0.015), although the percentage of stage IIIb-IV disease was similar (53% and 46%; nonsignificant) and they had a poorer estimated survival of 14.3 (13.0-18.5) months (p = 0.0024). Males smoked more than females (median 41 versus 30 pack-yrs; p < 0.001). Quitting smoking delayed age at diagnosis by 11 yrs for females (p = 0.0035) and 8 yrs for males (p < 0.001). Our results support the hypothesis that carcinogenesis differs between males and females, and between female smokers and never-smokers.
Collapse
|
90
|
Uhry Z, Hédelin G, Colonna M, Duffy S. Reply to: Lost opportunity to usefully examine French breast cancer screening mortality. Cancer Epidemiol 2011. [DOI: 10.1016/j.canep.2011.02.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
91
|
Uhry Z, Hédelin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P, Molinié F, Trétarre B, Rogel A, Courtial I, Danzon A, Guizard A, Ancelle-Park R, Eilstein D, Duffy S. Modelling the effect of breast cancer screening on related mortality using French data. Cancer Epidemiol 2011; 35:235-42. [DOI: 10.1016/j.canep.2010.10.009] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2010] [Revised: 04/22/2010] [Accepted: 10/31/2010] [Indexed: 11/29/2022]
|
92
|
Olive F, Gomez F, Schott AM, Remontet L, Bossard N, Mitton N, Polazzi S, Colonna M, Trombert-Paviot B. Erratum à l’article : « Analyse critique des données du PMSI pour l’épidémiologie des cancers : une approche longitudinale devient possible » [Rev Epidemiol Sante Publique 59;2011:53–8]. Rev Epidemiol Sante Publique 2011. [DOI: 10.1016/j.respe.2011.03.058] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
93
|
Romano G, Colonna M, Gnoni A, Leo SA, Nuzzo C, Forcignano R, Veltri E, Lorusso V. How often is the planned dose intensity of XELOX and FOLFOX administered to colon cancer patients older than age 65 in clinical practice? J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e14113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
94
|
Di Cocco B, Colonna M, Salesi N, Moscato M, Calogero A, Pacini L, Veltri E. EGFR and K-ras status and clinical outcomes in patients with advanced NSCLC treated with erlotinib: Our experience. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e18076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
95
|
Rossi L, Veltri E, Colonna M, Zoratto F, Vari S, Mottolese M, Di Seri M, Romiti A, Longo F, Giannarelli D, Tomao S. Biomolecular, biochemical, and radiologic evaluation and safety of chemotherapy with bevacizumab in treatment of patients affected by mCRC. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e14140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
96
|
Salesi N, Colonna M, Di Cocco B, Moscato M, Calogero A, Pacini L, Veltri E. Paclitaxel with bevacizumab (PB) as first-line therapy for metastatic breast cancer: Our experience. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e11013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
97
|
Rossi L, Veltri E, Di Seri M, Vari S, Colonna M, Adua D, Longo F, Zoratto F, Mottolese M, Tomao S. Biomolecular, biochemical, and radiologic evaluation of patients on anti-VEGF treatment for mCRC. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
556 Background: K-ras mutation is a negative predictor of clinical benefit (CB) from anti-EGFR treatment in mCRC. Bevacizumab combined with chemotherapy prolongs both PFS and OS in first-line treatment of mCRC. Previously data suggested that this results are independent of K-ras status. We conducted a study to investigate the CB of Bevacizumab in treatment of mCRC according to K-ras status and to evaluate timing of response to treatment trough the correlation between tumor markers values and clinical responses. Finally we evaluated CB in patients affected by mCRC with only hepatic metastases vs patients with multiple metastasis sites. Methods: 82 patients were enrolled and underwent first-line chemotherapy with Folfiri or FolFoX and bevacizumab. Tissue samples were analyzed for DNA sequencing in order to identify K-ras mutations in codons 12 and 13. Before therapy all patients were investigated with CT scan and with a blood sample to define tumor markers values; a new evaluation of tumor markers after 2 months of chemotherapy was performed and a CT scan after 3 months. Results: An overall objective response rate (RR) of 40% and a CB of 79% were obtained, with a correlation between tumor markers values and clinical response of 89%. 49% of population presented only hepatic metastases while other 51% showed multiple metastatic sites. RR in exclusive hepatic metastatic group was 45% vs 33% multiple metastatic sites group, CB was 90% vs 66% respectively. No grade 3 or 4 bevacizumab associated toxicity was showed in patients. K-ras mutations were investigated in 75 of 82 patients. 49 patients were wild-type (wt 65%) while 26 patients were mutated (mut 35%). RR in wt group was 45% vs 35% in mut group, while CB was 82% vs 81% respectively. Correlation between tumor markers values and clinical response was 90% in wt group vs 93% in mut group. Conclusions: RR in two K-ras groups was different with an advantage in K-ras wt group, but this difference does not observe in CB. Bevacizumab provides significant RR and CB after a short time of treatment and tumor markers values could be an optimal correlative parameters of early clinical response. Bevacizumab provides significant CB in patients with only hepatic metastases vs patients with multiple metastatic sites. No significant financial relationships to disclose.
Collapse
|
98
|
Lotti N, Colonna M, Fiorini M, Finelli L, Berti C. Poly(butylene terephthalate) modified with ethoxylated bisphenol S with increased glass transition temperature and improved thermal stability. POLYMER 2011. [DOI: 10.1016/j.polymer.2011.01.018] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
99
|
Daubisse-Marliac L, Delafosse P, Boitard J, Poncet F, Grosclaude P, Colonna M. Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol 2011; 22:329-34. [DOI: 10.1093/annonc/mdq396] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
100
|
Pierroutsakou D, Parascandolo C, Silvestri R, Agodi C, Alba R, Baran V, Boiano A, Colonna M, Coniglione R, De Filippo E, De Rosa A, Del Zoppo A, Di Toro M, Emanuele U, Farinon F, Guglielmetti A, Inglima G, La Commara M, Maiolino C, Martin B, Mazzocco M, Mazzocchi C, Molini P, Rizzo C, Romoli M, Sandoli M, Santonocito D, Signorini C, Soramel F, Trifirò A, Trimarchi M. Dynamical Dipole mode in heavy-ion fusion reactions by using stable and radioactive beams. EPJ WEB OF CONFERENCES 2011. [DOI: 10.1051/epjconf/20111710006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|